Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 528

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 528
---
 F-73

TABLE OF CONTENTS

LIMINATUS PHARMA, LLC STATEMENTS OF CASH FLOWS
(in thousands)

| ​                                                                            
 ​                                                                            | ​ 
 ​ | ​ 
 ​ | Year ended December 31, 
 2023                    |   |        |   | ​ | ​ | 2022 |   |        |   | ​ 
 ​ |
|:-----------------------------------------------------------------------------|:--|:--|:------------------------|:--|-------:|:--|:--|:--|:-----|:--|-------:|:--|:--|
| Cash Flows from Operating Activities:                                        | ​ | ​ | ​                       | ​ |      ​ | ​ | ​ | ​ | ​    | ​ |      ​ | ​ | ​ |
| Net loss                                                                     | ​ | ​ | ​                       | $ | -4,984 | ​ | ​ | ​ | ​    | $ | -2,928 | ​ | ​ |
| Adjustments to reconcile net loss to net cash used in operating activities:  | ​ | ​ | ​                       | ​ |      ​ | ​ | ​ | ​ | ​    | ​ |      ​ | ​ | ​ |
| Non-cash Research and development expense                                    | ​ | ​ | ​                       | ​ |      — | ​ | ​ | ​ | ​    | ​ |    900 | ​ | ​ |
| Changes in operating assets and liabilities:                                 | ​ | ​ | ​                       | ​ |      ​ | ​ | ​ | ​ | ​    | ​ |      ​ | ​ | ​ |
| Advances for research and development                                        | ​ | ​ | ​                       | ​ |  1,684 | ​ | ​ | ​ | ​    | ​ |    953 | ​ | ​ |
| Due from related party                                                       | ​ | ​ | ​                       | ​ |    -26 | ​ | ​ | ​ | ​    | ​ |    -46 | ​ | ​ |
| Deferred transaction costs                                                   | ​ | ​ | ​                       | ​ |   -840 | ​ | ​ | ​ | ​    | ​ |      — | ​ | ​ |
| Prepaid and other current assets                                             | ​ | ​ | ​                       | ​ |    -12 | ​ | ​ | ​ | ​    | ​ |    -10 | ​ | ​ |
| Accounts payable and accrued expenses                                        | ​ | ​ | ​                       | ​ |    425